In addition, we research peptides and biomolecules involved in stem cell recruitment, expansion and differentiation.

State of the art facilities at

Olympus Medical Centre Olympic Park

Olympus Technology

Olympus Stem Cell uses adipose-derived stem cells for deployment & clinical research. Early stem cell research has traditionally been associated with the controversial use of embryonic stem cells.

The new focus is on non-embryonic adult mesenchymal stem cells which are found in a person’s own blood, and fat.

A recent technological breakthrough enables us to now use adipose (fat) derived stem cells.

Autologous stem cells from a person’s own fat are easy to harvest safely under local anesthesia and are abundant in quantities up to 2500 times those seen in bone marrow.

Clinical success and favorable outcomes appear to be related directly to the quantity of stem cells deployed.

Once these adipose derived stem cells are administered back in to the patient, they have the potential to repair human tissue by forming new cells of mesenchymal origin, such as cartilage, bone, ligaments, tendons, nerve, fat, muscle, blood vessels, and certain internal organs. Stem cells’ ability to form cartilage and bone makes them potentially effective in the treatment of degenerative orthopedic conditions. Associate Professor Vickers published in 2016 and 2017 in international medical journals on the use of stem cells in nerve disturbance.

We have both anecdotal and experimental evidence that stem cell therapy is effective in healing and regeneration.

Stem cells seek out damaged tissues in order to repair the body naturally. The literature and internet is in abundance of successful testimonials but we are still awaiting definitive studies demonstrating efficacy of stem cell therapy.

Such data may take five or ten years to accumulate.

In an effort to provide relief for patients suffering from certain degenerative diseases that have been resistant to common modalities of treatment, we are initiating pilot studies as experimental tests of treatment effectiveness with very high numbers of adipose derived stem cells obtained from fat.

Adipose fat is an abundant and reliable source of stem cells.

Olympus Stem Cell cell harvesting and isolation techniques are based on known technology.

This new technological breakthrough allows patients to safely receive their own autologous stem cells in extremely large quantities.

Our treatments and research are patient funded and we have endeavored successfully to make it affordable. All of our sterile procedures are non-invasive and done under local anaesthesia or sedation.

Patients who are looking for non-surgical alternatives to their degenerative disorders can participate in our trials by filling out our treatment application to determine if they are candidates.

Olympus Stem Cell is proud to be state of the art in the new field of Regenerative Medicine.

Cell Banking

Cryo-preservation and banking of adipose derived stem cells is possible.

Autologous lipo-aspirate can be frozen as fat or as SVF. SVF can be frozen for repeated deployments and in the near future (pending regulatory approval) expanded into nearly unlimited quantities of autologous stem cells.

This will provide patients with their own personal stem cell line that could be used for possible medical treatment in the future.

What specialities and Proceduralists are represented at Olympus Stem Cells?

A/Professor E. Russell Vickers

Founder of Olympus Stem Cells

Many generalists and medical specialists are represented at Olympus Stem Cells including general practice medicine, sports medicine, oral and maxillofacial surgery, rehabilitation medicine, orthopedics to name a few.

We also provide services from psychologists and medical scientists qualified in diagnosis, evaluation and treatment.

Our network continues to grow and add experts from various other fields.

Olympus Stem Cell is a multi-specialty stem cell centre in Australia.

Our Director, Associate Professor E. Russell Vickers, Ph.D., FFPM (ANZCA) is a recognised specialist in his field of MaxilloFacial Surgery and is a world leader in the use of stem cells in the head and neck region.

His medical and dental research including publications are extensive and range from Dental and Oral Surgery to Stem Cells and Pain Research since his initial training in Stem Cells at the Australian Government Stem Cell core facility in Brisbane, Australia in 2012.

Professor Vickers has academic appointments at The University of Queensland and The Charles Sturt University, NSW and regularly gives lectures on stem cells nationally and internationally.

Together with Olympus Stem Cells, therapy can be effectively coordinated, predominantly through one’s own stem cells, but additionally other avenues of regenerative medicine can also be explored.

For example, if you have a knee problem, our staff at Olympus may collaborate with other affiliates with specific expertise in treating certain joints. It is our belief that stem cell therapy can be the likely foundation for regenerative treatment.

It should also be noted that all treatments are currently in the investigational stage.

While we recognize our patients are seeking improvement in their condition through stem cell therapy, each treatment is part of an ongoing investigation to establish optimal parameters for treatment, to evaluate for effectiveness of treatment and any adverse effects.

It is essential that patients understand that they are potentially participating in these investigational (research) analyses.

The Olympus hospital scientist will appraise you of the possibility of enrolling you into a study.

Our research director, A/Professor E. Russell Vickers facilitates and is responsible for the research protocols.

Once sufficient information is appropriately documented and statistically significant, then data (validated by A/Professor Vickers) may be presented to medical authorities for consideration of making an actual claim.